Inhibition of nucleic acid synthesis in P388 lymphocytic leukemia cells in culture by cis-platinum derivatives.

No abstract is available for this paper.

• Publication year

  1990

• Venue

  Biomedica biochimica acta

• Publication date

  Unknown publication date

• Fields of study

  Medicine, Chemistry

• Identifiers
  PMID 1704216
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The inhibition of P338 lymphocytic leukemia DNA polymerase alpha activity by cis-diamminedichloroplatinum(II) and related derivatives.

  1989cited by this paper
• Mechanism of cis-diamminedichloroplatinum(II)-induced cytotoxicity: role of G2 arrest and DNA double-strand breaks.

  1988cited by this paper
• Effects of the bidentate malonate ligand on the utilization and cytotoxicity of platinum compounds in the L1210 cell line.

  1986cited by this paper
• Mechanism of cytotoxicity of anticancer platinum drugs: evidence that cis-diamminedichloroplatinum(II) and cis-diammine-(1,1-cyclobutanedicarboxylato)platinum(II) differ only in the kinetics of their interaction with DNA.

  1986cited by this paper
• Quantitative aspects of the formation and loss of DNA interstrand crosslinks in Chinese hamster cells following treatment with cis-diamminedichloroplatinum(II) (cisplatin). II. Comparison of results from alkaline elution, DNA renaturation and DNA sedimentation studies.

  1981cited by this paper
• Induction of deoxyribonucleic acid damage in HeLa S3 cells by cytotoxic and antitumor sesquiterpene lactones.

  1981cited by this paper
• Effect of calcium on the recovery and distribution of DNA polymerase alpha from cultured human cells.

  1977cited by this paper
• Resolution of alpha, beta and gamma DNA of Saccharomyces cerevisiae with the antitumor drug cis-Pt (NH3)2CL2. Evidence for preferential drug binding by GpG sequences of DNA.

  1976cited by this paper
• Mode of action of the antitumor compound bruceantin, an inhibitor of protein synthesis.

  1976cited by this paper
• Inhibition of macromolecular synthesis in L1210 mouse leukemia ascites cells by hycanthone.

  1975cited by this paper
• Effect of neocarzinostatin on DNA synthesis in L1210 cells.

  1974cited by this paper
• Specific binding of antitumour drug cis-Pt(NH3)2Cl2 to DNA rich in guanine and cytosine

  1974cited by this paper
• Inhibition of thymidine phosphorylation and DNA and histone synthesis in Ehrlich ascites carcinoma.

  1970cited by this paper
• Inhibitory effects of anti‐tumor platinum compounds on DNA, RNA and protein syntheses in mammalian cells in vitro

  1970cited by this paper
• Purification and properties of a bacterial carbamyl phosphate synthetase.

  1966cited by this paper
• ISOLATION OF NUCLEI FROM MAMMALIAN TISSUES THROUGH THE USE OF TRITON X-100

  1964cited by this paper
• Enzymatic phosphorylation of deoxycytidylic acid.

  1958cited by this paper
• Colorimetric determination of carbamylamino acids and related compounds.

  1954cited by this paper
• Protein measurement with the Folin phenol reagent.

  1951cited by this paper

• Absence of misincorporation of pyrimidines in DNA after treatment with a combination of cisplatin (CIS-diammine-dichloro-platinum) amd 5-fluorouracil of mouse sarcoma cells.

  1996cites this paper
• The effects of boron containing peptides on L1210 lymphoid leukemia metabolism

  1993cites this paper
• [Cell cultures: usefulness in biomedical research].

  1992cites this paper
• DNA interaction with metal complexes and salts of substituted boranes and hydroborates in murine and human tumor cell lines.

  1991cites this paper